Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: Implications for opiate and psychostimulant cross-sensitization
Al. Svingos et al., Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: Implications for opiate and psychostimulant cross-sensitization, SYNAPSE, 34(1), 1999, pp. 1-10
Opiate- and psychostimulant-induced modulation of dopamine transmission in
the nucleus accumbens shell (AcbSh) is thought to play a key role in their
potent reinforcing and locomotor effects. To investigate the cellular basis
for potential functional interactions involving opiates active at the delt
a-opioid receptor (DOR) and psychostimulants that bind selectively to the d
opamine transporter (DAT), we examined the electron microscopic localizatio
n of their respective antisera in rat AcbSh. DOR immunoperoxidase labeling
was seen primarily, and DAT immunogold particles exclusively, in axon termi
nals. In these terminals, DOR immunoreactivity was prominently associated w
ith discrete segments of the plasma membrane and the membranes of nearby sm
all synaptic and large dense core vesicles. DAT immunogold particles were a
lmost exclusively distributed along nonsynaptic axonal plasma membranes. Th
irty-nine percent DOR-labeled profiles (221/566) either apposed DAT-immunor
eactive terminals or also contained DAT Of these 221 DOR-labeled profiles,
13% were axon terminals containing DAT and 15% were dendritic spines appose
d to DAT-immunoreactive terminals. In contrast, 70% were morphologically he
terogeneous axon terminals and small axons apposed to DAT-immunoreactive te
rminals. Our results indicate that DOR agonists in the AcbSh can directly m
odulate the release of dopamine, as well as postsynaptic responses in spiny
neurons that receive dopaminergic input, but act principally to control th
e presynaptic secretion of other neurotransmitters whose release may influe
nce or be influenced by extracellular dopamine. Thus, while opiates and psy
chostimulants mainly have differential sites of action, cross-sensitization
of their addictive properties may occur through common neuronal targets. (
C) 1999 Wiley-Liss, Inc.